A qualitative immunoassay to detect the presence of antibodies (IgG) directed against hepatitis C virus (HCV) in a serum sample. This test is used as an initial screening test to detect exposure to the virus, as these antibodies appear 4-10 weeks after infection and may remain positive even after recovery.